Hyderabad-based vaccine maker Bharat Biotech said it has signed an agreement to supply 20 million doses of its Covid-19 shot Covaxin to Brazil during the second and third quarters of 2021.
The firm said there is 'strong interest' in Covaxin and it is committed to supplying promptly. This is significant in the backdrop of the mutant strain identified in Brazil.
In January, Bharat Biotech had indicated that it has signed an agreement with Precisa Medicamentos, a wholesaler of drugs in Brazil to supply Covaxin to that country.
A team from Precisa Medicamentos met Bharat Biotech chairman and managing director Krishna